HOUSHMAND, MOHAMMAD
 Distribuzione geografica
Continente #
NA - Nord America 468
EU - Europa 217
AS - Asia 127
AF - Africa 6
OC - Oceania 1
Totale 819
Nazione #
US - Stati Uniti d'America 458
IT - Italia 87
SG - Singapore 51
IE - Irlanda 41
CN - Cina 38
SE - Svezia 38
DE - Germania 11
CA - Canada 10
IN - India 10
UA - Ucraina 9
FR - Francia 8
HK - Hong Kong 8
FI - Finlandia 6
NG - Nigeria 6
VN - Vietnam 6
ID - Indonesia 5
NL - Olanda 4
BE - Belgio 3
DK - Danimarca 3
KR - Corea 3
JO - Giordania 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
HR - Croazia 1
IR - Iran 1
LT - Lituania 1
NO - Norvegia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 819
Città #
Chandler 100
Santa Clara 61
Dublin 41
Singapore 38
Turin 30
Fairfield 22
Nyköping 21
Ashburn 17
Torino 16
Columbus 12
Medford 11
Princeton 10
Woodbridge 10
Tai Wan 8
Wilmington 8
Houston 7
Québec 7
Rome 7
Uppsala 7
Abuja 6
Ann Arbor 6
Cambridge 6
New York 6
Hangzhou 5
Helsinki 5
Jakarta 5
Novara 5
Seattle 5
Beijing 4
Catania 4
Chennai 4
Frankfurt am Main 4
Hebei 4
Hyderabad 4
Milan 4
San Diego 4
Brussels 3
Capriate San Gervasio 3
Copenhagen 3
Falls Church 3
Seoul 3
Amman 2
Dong Ket 2
Ho Chi Minh City 2
San Mateo 2
Sunnyvale 2
West Jordan 2
Alessandria 1
Alton 1
Amsterdam 1
Bergen 1
Berlin 1
Bratislava 1
Buffalo 1
Cameri 1
Civitavecchia 1
Drakulica Rijeka 1
Duncan 1
Florence 1
Grugliasco 1
Guangzhou 1
Guestrow 1
Guiyang 1
Gunzenhausen 1
Gurgaon 1
Jinan 1
Lappeenranta 1
Montreal 1
Mumbai 1
Munich 1
Nole 1
Olomouc 1
Omaha 1
Ottawa 1
Paris 1
Redwood City 1
Riyadh 1
Taipei 1
Toronto 1
Vienna 1
Washington 1
Wuhan 1
Xian 1
Yangzhou 1
Totale 578
Nome #
A differentiating and apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor 115
Nanocarriers as magic bullets in the treatment of leukemia 112
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety 105
A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor 74
The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia 71
The inhibition of human DHODH by M433 leads to differentiation and apoptosis in acute myeloid leukemia 63
Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia 58
Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor 56
Targeting chronic myeloid leukemia stem/progenitor cells using venetoclax-loaded immunoliposome 55
Hydroxylated heterocycles as a bioisosteric tool to Modulate the carboxylic function into design potent human Dihydroorotate Dehydrogenase inhibitors 55
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 49
Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells 14
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 9
Totale 836
Categoria #
all - tutte 3.728
article - articoli 0
book - libri 0
conference - conferenze 2.037
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 2 43 0 0 1 2 0 13 2 12
2021/2022154 4 1 12 4 7 6 3 12 3 32 47 23
2022/2023310 24 37 14 21 19 73 12 24 38 24 12 12
2023/2024114 11 15 7 8 6 21 9 1 3 6 14 13
2024/2025183 8 20 11 47 72 25 0 0 0 0 0 0
Totale 836